File: '\\swfile\EmailIn\20260402 052105 Attachment TripSitter Clinic Ltd. - Closing Press Release SFD (4-2-2026).docx'

- 2 -

TRIPSITTER CLINIC LTD.

77 King Street West, Suite 700

Toronto, Ontario M5K 1G8

NEWS RELEASE

TRIPSITTER COMPLETES DEBT SETTLEMENT

April 2, 2026 - Vancouver, British Columbia - TripSitter Clinic Ltd. (the "Company" or "TripSitter") (CSE: KETA) further to the Company's debt settlement as announced March 26, 2026, the Company has settled $373,250.00 in liabilities through the issuance of 6,635,555 common shares of the Company at a deemed price of $0.05625 per share (the "Debt Settlement"). The common shares issued are subject to a hold period expiring August 3, 2026.

Zeeshan Khan, the Company's CFO and Cabazon Capital Corp., an insider of the Company, participated in the Debt Settlement. As insiders of the Company participated in this Settlement, it is deemed to be a "related party transaction" as defined under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101").

Neither the Company, nor to the knowledge of the Company after reasonable inquiry, a related party, has knowledge of any material information concerning the Company or its securities that has not been generally disclosed.

The Debt Settlement is exempt from the formal valuation and minority shareholder approval requirements of Multilateral Instrument MI 61-101 (the "Instrument") pursuant to subsections 5.5(g) and 5.7(1)(e) of the Instrument in respect of such insider participation.

The Company did not file a material change report more than 21 days before the expected closing of the Debt Settlement because the details of the participation therein by related parties of the Company were not settled until shortly prior to closing of the Debt Settlement and the Company wished to close on an expedited basis for business reasons.

Early Warning Disclosure

Immediately prior to the Debt Settlement, Cabazon Capital Corp. ("Cabazon"), a Cayman Islands company controlled by Craig Bridgman, owned and controlled 1,128,000 common shares of the Company, representing approximately 16.94% of the outstanding common shares. As a result of the common shares issued to Cabazon pursuant to the Debt Settlement, Cabazon has ownership and control over 2,648,000 common shares of the Company, representing 19.92% of the issued and outstanding Common Shares.

Immediately prior to the Debt Settlement, Oregon Management FZ-LLC ("Oregon"), a UAE company controlled by Eric Halff, did not own and control any common shares of the Company. As a result of the common shares issued to Oregon pursuant to the Debt Settlement, Oregon has ownership and control over 2,400,000 common shares of the Company, representing 18.05% of the issued and outstanding Common Shares.

Cabazon and Oregon acquired the above-noted common shares for investment purposes. Cabazon and/or Oregon may in the future take such actions in respect of its holdings in the Company as it may deem appropriate in light of the circumstances then existing, including the purchase of additional securities of the Company through open market purchases or privately negotiated transactions or the sale of all or a portion of its individual holdings in the open market or in privately negotiated transactions to one or more purchasers, subject in each case to applicable securities law.

To obtain a copy of the early warning reports under applicable Canadian provincial securities legislation, please go to the Company's profile under SEDAR+ at www.sedarplus.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Dr. John Huber, CEO

Email: dr.huber@tripsitter.clinic

Phone: 437-500-0528

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release.

CAUTIONARY DISCLAIMER STATEMENT

This news release may include certain "forward-looking statements" under applicable Canadian securities legislation, including with respect to the business objectives of the Company. Forward-looking statements are necessarily based upon several estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties, and uncertain capital markets. Readers are cautioned that actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.